Project Details
Description
Phase I safety and immunogenicity study of the cytomegalovirus (CMV) recombinant glycoprotein B vaccine in paired CMV seronegative.....
| Status | Finished |
|---|---|
| Effective start/end date | 8/9/06 → 9/30/07 |
Funding
- Sanofi Pasteur
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.